pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • VASERETIC
    VASERETIC (ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE)
    no indication BAUSCH
  • VASOPRESSIN IN 0.9% SODIUM CHLORIDE
    VASOPRESSIN IN 0.9% SODIUM CHLORIDE
    no indication BAXTER HLTHCARE CORP
  • Phase 1
    VAX-014
    Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial B… Vaxiion Therapeutics Inc
  • Phase 2
    VAX-24
← prev
page 171 of 271
next →
Pain89
Neurology1
Streptococcal Pneumonia
$PCVX Vaxcyte, Inc.
  • Phase 3
    VAX-31
    Streptococcal Pneumonia$PCVX Vaxcyte, Inc.
  • Preclinical
    VAXA-1
    Streptococcal Infections$PCVX Vaxcyte, Inc.
  • Preclinical
    VB-0004
    Kidney Fibrosis Vectus Biosystems Ltd
  • Preclinical
    VB-001
    Acute Ischemic Stroke VST Bio Corp
  • Phase 2
    VB-1953
    Acne Vulgaris$HIND Vyome Holdings, Inc
  • Phase 2
    VBC-103
    Metastatic Transitional (Urothelial) Tract Cancer Avenzo Therapeutics Inc
  • Phase 2
    VBI-1901
    Recurrent Glioblastoma Multiforme (GBM) VBI Vaccines Inc
  • Preclinical
    VBX-100
    Irritable Bowel Syndrome$RNGE RANGE IMPACT, INC.
  • Phase 2
    VC-01
    Type 1 Diabetes (Juvenile Diabetes)$VERX Vertex, Inc.
  • Phase 2
    VC-02
    PEC-Direct
    Type 1 Diabetes (Juvenile Diabetes) ViaCyte, Inc.
  • Phase 2
    VCA-894A
    Charcot-Marie-Tooth Disease Type II$VNDA Vanda Pharmaceuticals Inc.
  • Phase 1
    VCC-001
    Renal Cell Carcinoma Vaccentis AG
  • Phase 2
    VCT-220
    Obesity CORXEL Pharmaceuticals (Shanghai) Co Ltd
  • Phase 3
    VE-303
    Clostridioides difficile Infections (Clostridium difficil… Vedanta Biosciences Inc
  • VEKLURY
    VEKLURY (REMDESIVIR)
    1 INDICATIONS AND USAGE VEKLURY is indicated for the trea…$GILD GILEAD SCIENCES, INC.
  • VENCLEXTA
    VENCLEXTA (VENETOCLAX)
    1 INDICATIONS AND USAGE VENCLEXTA is a BCL-2 inhibitor in…$ABBV AbbVie Inc.
  • VENLAFAXINE
    VENLAFAXINE
    no indication ALKEM LABS LTD
  • Marketed
    VERAPAMIL HYDROCHLORIDE
    VERAPAMIL HYDROCHLORIDE
    Atrial Fibrillation Armas Pharmaceuticals Inc
  • Preclinical
    VERI-101
    Solid Tumor VerImmune Inc
  • Preclinical
    VERSAMAB-101
    Acute Spinal Cord Injury VersaPeutics Inc
  • Phase 2
    VG-161
    Bile Duct Cancer (Cholangiocarcinoma) Virogin Biotech Ltd
  • Phase 1
    VG-201
    Colorectal Cancer Virogin Biotech Ltd
  • Phase 1
    VG-203
    Solid Tumor Virogin Biotech Ltd
  • Phase 2
    VG-801
    Unspecified Ophthalmological Disorders VeonGen Therapeutics GmbH
  • Preclinical
    VH-310
    Human Immunodeficiency Virus (HIV) Infections (AIDS) ViiV Healthcare UK Ltd
  • Phase 2
    VH-4524184
    Human Immunodeficiency Virus (HIV) Infections (AIDS) ViiV Healthcare UK Ltd